We are live on
!
Find out more
ACM
Argyle Capital Management Portfolio holdings
AUM
$347M
1-Year Est. Return
44.33%
This Fund
S&P 500
This Quarter
Est. Return
+0.84%
1 Year Est. Return
+44.33%
3 Year Est. Return
+95.77%
5 Year Est. Return
+124.66%
10 Year Est. Return
+325.03%
AUM
$174M
AUM Growth
–
Cap. Flow
+$176M
Cap. Flow
% of AUM
100.96%
Top 10 Holdings %
Top 10 Hldgs %
24.86%
Holding
108
New
108
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$4.91M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$4.88M |
| 3 |
Merck
MRK
|
+$4.75M |
| 4 |
Verizon
VZ
|
+$4.67M |
| 5 |
AT&T
T
|
+$4.31M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.77% |
| 2 | Technology | 14.15% |
| 3 | Industrials | 11.26% |
| 4 | Energy | 10.86% |
| 5 | Consumer Staples | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bristol-Myers Squibb
BMY
$133B
| $5.02M | 2.88% |
+112,348
| New | +$4.88M |
|
|
2
Pfizer
PFE
$143B
| $4.72M | 2.71% |
+177,740
| New | +$4.91M |
|
|
3
Merck
MRK
$322B
| $4.72M | 2.7% |
+106,441
| New | +$4.75M |
|
|
4
Verizon
VZ
$195B
| $4.61M | 2.64% |
+91,544
| New | +$4.67M |
|
5
Microsoft
MSFT
$3.45T
| $4.22M | 2.42% |
+122,077
| New | +$4M |
|
|
6
AT&T
T
$159B
| $4.15M | 2.38% |
+155,096
| New | +$4.31M |
|
7
Coca-Cola
KO
$377B
| $4.09M | 2.34% |
+101,993
| New | +$4.22M |
|
8
Amgen
AMGN
$208B
| $4.08M | 2.34% |
+41,299
| New | +$4.29M |
|
9
IBM
IBM
$211B
| $3.98M | 2.28% |
+21,779
| New | +$4.24M |
|
10
3M
MMM
$90.9B
| $3.79M | 2.17% |
+41,471
| New | +$3.77M |
|
11
Genuine Parts
GPC
$17.1B
| $3.74M | 2.14% |
+47,861
| New | +$3.71M |
|
12
McKesson
MCK
$100B
| $3.69M | 2.12% |
+32,250
| New | +$3.59M |
|
13
GE Aerospace
GE
$374B
| $3.54M | 2.03% |
+31,842
| New | +$3.53M |
|
14
Intel
INTC
$455B
| $3.43M | 1.97% |
+141,700
| New | +$3.35M |
|
15
Duke Energy
DUK
$97.8B
| $3.43M | 1.97% |
+50,838
| New | +$3.59M |
|
16
Johnson & Johnson
JNJ
$618B
| $3.38M | 1.94% |
+39,402
| New | +$3.34M |
|
|
SE
17
DELISTED
Spectra Energy Corp Wi
SE
| $3.37M | 1.93% |
+97,849
| New | +$3.08M |
|
18
United Parcel Service
UPS
$88.6B
| $3.34M | 1.92% |
+38,660
| New | +$3.32M |
|
19
Paychex
PAYX
$41.6B
| $3.23M | 1.85% |
+88,472
| New | +$3.26M |
|
20
Medtronic
MDT
$109B
| $3.15M | 1.81% |
+61,210
| New | +$3.03M |
|
21
Chevron
CVX
$392B
| $3.09M | 1.77% |
+26,106
| New | +$3.16M |
|
22
Hershey
HSY
$35.2B
| $2.96M | 1.7% |
+33,153
| New | +$2.93M |
|
|
RTN
23
DELISTED
Raytheon Company
RTN
| $2.88M | 1.65% |
+43,550
| New | +$2.75M |
|
|
PPL
24
PPL Corp
PPL
$26.5B
| $2.84M | 1.63% |
+100,789
| New | +$2.91M |
|
25
ConocoPhillips
COP
$147B
| $2.75M | 1.58% |
+45,544
| New | +$2.77M |
|
Similar funds
GCP
AWA
WC
LAM
FFA
VW
1CP
NC
Argyle Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Argyle Capital Management, which disclosed 108 positions worth $174M. Its ten largest holdings account for 25% of the portfolio.
Its largest position is Pfizer: 177,740 shares worth $4.72M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Technology and Industrials.
- Argyle Capital Management's largest Q2 2013 buy was Pfizer: 177,740 shares worth $4.72M.
- Argyle Capital Management's ten largest holdings make up 25% of its $174M portfolio in Q2 2013.
- Argyle Capital Management disclosed 108 positions in Q2 2013, its first 13F filing on record.
Based on Argyle Capital Management's 13F filing for Q2 2013, filed 31 Jul 2013.